Page last updated: 2024-08-17

adenosine monophosphate and moxifloxacin

adenosine monophosphate has been researched along with moxifloxacin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bellibas, SE; Green, CL; Krucoff, MW; Lambe, L; Prats, J; Whellan, DJ; Wijngaard, P	1

Trials

1 trial(s) available for adenosine monophosphate and moxifloxacin

Article	Year
Electrocardiographic safety of cangrelor, a new intravenous antiplatelet agent: a randomized, double-blind, placebo- and moxifloxacin-controlled thorough QT study. Journal of cardiovascular pharmacology, 2013, Volume: 62, Issue:5 Topics: Adenosine Monophosphate; Adolescent; Adult; Aza Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Follow-Up Studies; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Quinolines; Time Factors; Young Adult	2013

Article

Year

Electrocardiographic safety of cangrelor, a new intravenous antiplatelet agent: a randomized, double-blind, placebo- and moxifloxacin-controlled thorough QT study.

Journal of cardiovascular pharmacology, 2013, Volume: 62, Issue:5

Topics: Adenosine Monophosphate; Adolescent; Adult; Aza Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Follow-Up Studies; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Quinolines; Time Factors; Young Adult

2013